Regulations and Innovation in Tech

This chapter discusses the impact of recent government restrictions on the semiconductor and pharmaceutical industries, focusing on companies like NVIDIA and Bristol-Myers. It explores concerns about stifled innovation, competitiveness, and features insights on stock performance alongside a light-hearted exchange about stocks.